MedPath

Project Aura: Co-design of a Home-based Monitoring Service

Withdrawn
Conditions
Anemia of Chronic Kidney Disease
Interventions
Device: Blood measurement
Registration Number
NCT04112615
Lead Sponsor
Entia Ltd
Brief Summary

Co-design of a home-based haemoglobin monitoring system with participants with anaemia of chronic kidney disease.

Detailed Description

The device/monitoring system being developed measures the haemoglobin and haematocrit levels in blood from a single drop of blood. By measuring these blood parameter, participants are able to monitor their haemoglobin level at home.

The use of the device will take place in the participant's home to simulate what the investigators believe will be the ideal location for people who would prefer to self-manage their condition.

This study is a unique opportunity to gain feedback on the future design and development of a home-based monitoring system through user evaluation. As this is an adaptive/ iterative study design, this will give the Sponsor the opportunity to make changes to the user interface and user platform based on the feedback received from the end user.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healthcare professionalsBlood measurementHealthcare professionals come in to give feedback on the device and the system, from what results they would like to see and their concerns about patients using it.
Patients and/or carersBlood measurementPatients and/or their nominated carers come in to give feedback on the device and the system as a whole, from usability to design.
Primary Outcome Measures
NameTimeMethod
Qualitative capture of user feedback- focus groups12 months

User feedback gathered from participants using the blood measurement device will be used to inform the changes necessary to develop a successful home-based haemoglobin monitoring system.

Feedback will be analysed based on framework analysis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hull University Teaching Hospitals NHS Trust

🇬🇧

Hull, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath